National Institutes of Health · USA

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

Offen

Die Einreichungsfrist endet am 5. April 2027. Antragsberechtigte Gruppen laut Quelle: Small businesses.

Frist: 5. April 2027 (in 141 Tagen)
Fördersumme: Nicht angegeben — siehe offizielle Ausschreibung
Förderquote: Kein Pflicht-Eigenanteil angegeben; Förderquote nicht angegeben
Eigenanteil: Nicht erforderlich
Wahrscheinliche Antragstellende: KMU / Start-ups, Unternehmen Aus Quellkategorien oder Programmregeln; maßgeblich ist die Ausschreibung.
Fördergeber: National Institutes of Health
Referenz: PA-27-100
Assistance Listing (USA): 93.068 Chronic Diseases: Research, Control, and Prevention; 93.070 Environmental Public Health and Emergency Response; 93.073 Birth Defects and Developmental Disabilities - Prevention and Surveillance; 93.083 Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases; 93.084 Prevention of Disease, Disability, and Death by Infectious Diseases; 93.103 Food and Drug Administration Research; 93.113 Environmental Health; 93.121 Oral Diseases and Disorders Research; 93.136 Injury Prevention and Control Research and State and Community Based Programs; 93.142 NIEHS Hazardous Waste Worker Health and Safety Training; 93.143 NIEHS Superfund Hazardous Substances_Basic Research and Education; 93.172 Human Genome Research; 93.173 Research Related to Deafness and Communication Disorders; 93.213 Research and Training in Complementary and Integrative Health; 93.233 National Center on Sleep Disorders Research; 93.242 Mental Health Research Grants; 93.273 Alcohol Research Programs; 93.279 Drug Use and Addiction Research Programs; 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health; 93.307 Minority Health and Health Disparities Research; 93.313 NIH Office of Research on Women's Health; 93.326 Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention; 93.350 National Center for Advancing Translational Sciences; 93.351 Research Infrastructure Programs; 93.361 Nursing Research; 93.393 Cancer Cause and Prevention Research; 93.394 Cancer Detection and Diagnosis Research; 93.395 Cancer Treatment Research; 93.837 Cardiovascular Diseases Research; 93.838 Lung Diseases Research; 93.839 Blood Diseases and Resources Research; 93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders; 93.846 Arthritis, Musculoskeletal and Skin Diseases Research; 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research; 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders; 93.855 Allergy and Infectious Diseases Research; 93.859 Biomedical Research and Research Training; 93.865 Child Health and Human Development Extramural Research; 93.866 Aging Research; 93.867 Vision Research; 93.879 Medical Library Assistance
Zuletzt geprüft: 13. November 2026

Offizielle Ausschreibung öffnen ↗ Frist zum Kalender hinzufügen

Die offiziellen Beschreibungen sind in der Sprache des Fördergebers (meist Englisch); Zusammenfassung und Eckdaten auf dieser Seite sind auf Deutsch.

Über diese Ausschreibung

The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.

Wer kann sich bewerben?

Small businesses

Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Antragstellerkategorien sind nur ein Ausgangspunkt. Über die Antragsberechtigung entscheidet die offizielle Ausschreibung.

Themen

Health

So bewerben Sie sich

Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply: Not stated in the call text we hold — check the official page
Company stage: Not stated in the call text we hold — check the official page
Single applicant or consortium: Not stated in the call text we hold — check the official page
Where applicants must be based: Not stated in the call text we hold — check the official page
Where to apply: Not stated in the call text we hold — check the official page

Kontakt

National Institutes of Health · SEEDinfo@nih.gov · 301-402-2541

Offizielle Quellen

Offizielle Ausschreibungsseite

Die Angaben auf dieser Seite stammen aus der offiziellen Quelle und wurden zuletzt am 13. November 2026 geprüft. Maßgeblich sind immer die Unterlagen des Fördergebers einschließlich späterer Änderungen.